Skip to content

SPHERA FUNDS MANAGEMENT LTD.

Follow

13F filer, CIK 1496201, TEL AVIV, Israel

SPHERA FUNDS MANAGEMENT LTD. reported $707,470,841 across 113 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 35.41% of the portfolio.

Accepted , ingested 13F-HR 0001496201-26-000006

Period
2026-09-30
Reported value
$707M
Holdings
113
Top 10 weight
35.41%
New
32
Sold out
24

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TEVAnew+821,282$32.5M
ALNYadded+109,802$27.1M
SOXXnew+37,000$21M
METAnew+16,200$11.7M
CYTKadded+141,910$9.35M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TEVAexited-1,500,082-$50.8M
HELPreduced-1,232,602-$15.1M
INSMexited-118,800-$12.7M
SOLAREDGE TECHNOLOGIES INCexited-4,000,000-$7.75M
XENEexited-105,000-$6.34M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001496201-26-000006, largest first. % of portfolio is the value over $660,392,803, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 190,672 shares; 2025Q1: 465,526 shares; 2025Q2: 480,974 shares; 2025Q3: 219,910 shares; 2025Q4: 449,003 shares; 2026Q1: 1,339,971 shares; 2026Q2: 1,469,971 shares; 2026Q3: 1,321,861 shares 1,321,861$33.2M5.03%-148,110Timeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 821,282 shares 821,282$32.5M4.92%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,800 shares; 2026Q3: 120,602 shares 120,602$29.8M4.51%+109,802Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 153,021 shares; 2025Q1: 144,961 shares; 2025Q2: 326,718 shares; 2025Q3: 161,517 shares; 2025Q4: 91,717 shares; 2026Q1: 39,817 shares; 2026Q2: 219,987 shares; 2026Q3: 361,897 shares 361,897$23.9M3.61%+141,910Timeline
SOXXISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 37,000 shares 37,000$21M3.19%newTimeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 905,279 shares; 2025Q1: 366,608 shares; 2025Q2: 87,108 shares; 2025Q3: 40,746 shares; 2025Q4: 107,746 shares; 2026Q1: 245,246 shares; 2026Q2: 245,346 shares; 2026Q3: 311,717 shares 311,717$20.5M3.11%+66,371Timeline
TSEMTOWER SEMICONDUCTOR LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 166,149 shares; 2025Q1: 61,549 shares; 2025Q2: 264,722 shares; 2025Q3: 311,802 shares; 2025Q4: 122,513 shares; 2026Q1: 145,735 shares; 2026Q2: 108,265 shares; 2026Q3: 84,740 shares 84,740$19.3M2.92%-23,525Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,381,241 shares; 2025Q1: 1,663,974 shares; 2025Q2: 1,571,564 shares; 2025Q3: 387,716 shares; 2025Q4: 762,563 shares; 2026Q1: 724,563 shares; 2026Q2: 1,014,606 shares; 2026Q3: 1,007,278 shares 1,007,278$18.9M2.87%-7,328Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 147,000 shares; 2026Q1: 139,900 shares; 2026Q2: 328,550 shares; 2026Q3: 293,246 shares 293,246$17.6M2.66%-35,304Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 22,738 shares; 2025Q1: 22,738 shares; 2025Q2: 82,738 shares; 2025Q3: 82,738 shares; 2025Q4: 94,738 shares; 2026Q1: 92,526 shares; 2026Q2: 96,626 shares; 2026Q3: 75,763 shares 75,763$17.1M2.59%-20,863Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 335,024 shares; 2025Q2: 143,693 shares; 2025Q3: 98,526 shares; 2025Q4: 378,500 shares; 2026Q1: 416,340 shares; 2026Q2: 459,340 shares; 2026Q3: 501,540 shares 501,540$16.1M2.43%+42,200Timeline
NVMINOVA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 68,146 shares; 2025Q1: 90,697 shares; 2025Q2: 75,836 shares; 2025Q3: 43,896 shares; 2025Q4: 47,846 shares; 2026Q1: 53,366 shares; 2026Q2: 25,169 shares; 2026Q3: 39,044 shares 39,044$15M2.28%+13,875Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,300 shares; 2026Q1: 9,040 shares; 2026Q2: 17,419 shares; 2026Q3: 25,795 shares 25,795$13M1.97%+8,376Timeline
METAMETA PLATFORMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 21,001 shares; 2025Q1: 9,962 shares; 2025Q2: 8,526 shares; 2025Q3: 3,924 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 16,200 shares 16,200$11.7M1.78%newTimeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 921,111 shares; 2025Q1: 921,111 shares; 2025Q2: 583,105 shares; 2025Q3: 583,105 shares; 2025Q4: 861,105 shares; 2026Q1: 696,105 shares; 2026Q2: 720,057 shares; 2026Q3: 1,304,732 shares 1,304,732$11.5M1.73%+584,675Timeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 384,515 shares; 2025Q1: 304,515 shares; 2025Q2: 219,515 shares; 2025Q3: 219,515 shares; 2025Q4: 239,515 shares; 2026Q1: 269,515 shares; 2026Q2: 269,515 shares; 2026Q3: 269,515 shares 269,515$11.1M1.68%0Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 62,530 shares; 2026Q2: 62,530 shares; 2026Q3: 68,530 shares 68,530$11.1M1.68%+6,000Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 355,554 shares; 2025Q2: 356,453 shares; 2025Q3: 154,343 shares; 2025Q4: 71,843 shares; 2026Q1: 227,343 shares; 2026Q2: 417,564 shares; 2026Q3: 366,288 shares 366,288$9.96M1.51%-51,276Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 13,190 shares; 2025Q1: 11,690 shares; 2025Q2: 11,540 shares; 2025Q3: 10,040 shares; 2025Q4: 9,040 shares; 2026Q1: 9,040 shares; 2026Q2: 8,040 shares; 2026Q3: 8,040 shares 8,040$9.3M1.41%0Timeline
KLACKLA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 45,220 shares 45,220$8.81M1.33%newTimeline
LRCXLAM RESEARCH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 18,470 shares; 2026Q3: 25,900 shares 25,900$8.51M1.29%+7,430Timeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 90,000 shares; 2025Q1: 90,000 shares; 2025Q2: 86,000 shares; 2025Q3: 86,000 shares; 2025Q4: 86,000 shares; 2026Q1: 186,000 shares; 2026Q2: 286,000 shares; 2026Q3: 286,000 shares 286,000$8.16M1.24%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 196,408 shares; 2026Q3: 211,408 shares 211,408$8.12M1.23%+15,000Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 80,400 shares; 2026Q3: 80,400 shares 80,400$7.66M1.16%0Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 69,831 shares; 2025Q1: 52,831 shares; 2025Q2: 40,831 shares; 2025Q3: 40,831 shares; 2025Q4: 35,831 shares; 2026Q1: 28,831 shares; 2026Q2: 28,831 shares; 2026Q3: 28,831 shares 28,831$7.63M1.16%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 544,563 shares; 2026Q1: 343,563 shares; 2026Q2: 254,250 shares; 2026Q3: 304,250 shares 304,250$7.59M1.15%+50,000Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 53,538 shares; 2026Q2: 63,538 shares; 2026Q3: 114,738 shares 114,738$7.51M1.14%+51,200Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 410,417 shares; 2026Q1: 321,917 shares; 2026Q2: 416,417 shares; 2026Q3: 383,417 shares 383,417$7.32M1.11%-33,000Timeline
AMATAPPLIED MATLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 18,000 shares; 2025Q2: 18,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 11,040 shares; 2026Q3: 14,300 shares 14,300$7.31M1.11%+3,260Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 73,716 shares 73,716$7.3M1.11%newTimeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 388,183 shares; 2025Q1: 383,856 shares; 2025Q2: 309,931 shares; 2025Q3: 119,406 shares; 2025Q4: 63,953 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 229,700 shares 229,700$7.29M1.1%newTimeline
CAMTCAMTEK LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 36,287 shares; 2025Q1: 23,086 shares; 2025Q2: 31,976 shares; 2025Q3: 29,048 shares; 2025Q4: 39,498 shares; 2026Q1: 53,020 shares; 2026Q2: not reported; 2026Q3: 46,800 shares 46,800$7.27M1.1%newTimeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 59,600 shares; 2025Q1: 59,600 shares; 2025Q2: 48,600 shares; 2025Q3: 48,600 shares; 2025Q4: 48,600 shares; 2026Q1: 48,600 shares; 2026Q2: 58,600 shares; 2026Q3: 48,600 shares 48,600$7.06M1.07%-10,000Timeline
NVCTNUVECTIS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 382,945 shares; 2026Q3: 323,425 shares 323,425$6.83M1.03%-59,520Timeline
NVSNOVARTIS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,000 shares; 2025Q1: 50,000 shares; 2025Q2: 37,000 shares; 2025Q3: 37,000 shares; 2025Q4: 37,000 shares; 2026Q1: 37,000 shares; 2026Q2: 50,000 shares; 2026Q3: 45,000 shares 45,000$6.41M0.97%-5,000Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 34,256 shares; 2025Q1: 30,256 shares; 2025Q2: 25,256 shares; 2025Q3: 25,256 shares; 2025Q4: 25,256 shares; 2026Q1: 30,256 shares; 2026Q2: 30,256 shares; 2026Q3: 22,256 shares 22,256$5.82M0.88%-8,000Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 27,876 shares; 2026Q3: 160,237 shares 160,237$5.68M0.86%+132,361Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 799,957 shares; 2025Q3: 643,957 shares; 2025Q4: 598,534 shares; 2026Q1: 574,029 shares; 2026Q2: 499,029 shares; 2026Q3: 385,329 shares 385,329$5.52M0.84%-113,700Timeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 489,207 shares; 2026Q2: 652,590 shares; 2026Q3: 638,690 shares 638,690$5.43M0.82%-13,900Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,243,039 shares; 2025Q1: 1,764,387 shares; 2025Q2: 1,764,387 shares; 2025Q3: 1,794,387 shares; 2025Q4: 1,316,212 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,222,687 shares 1,222,687$5.17M0.78%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 228,776 shares; 2025Q1: 267,385 shares; 2025Q2: 100,085 shares; 2025Q3: 352,558 shares; 2025Q4: 300,623 shares; 2026Q1: 809,333 shares; 2026Q2: 588,494 shares; 2026Q3: 338,643 shares 338,643$5.09M0.77%-249,851Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 251,935 shares; 2025Q1: 241,935 shares; 2025Q2: 209,837 shares; 2025Q3: 434,837 shares; 2025Q4: 932,247 shares; 2026Q1: 419,247 shares; 2026Q2: 483,747 shares; 2026Q3: 416,747 shares 416,747$4.78M0.72%-67,000Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 538,111 shares; 2025Q1: 527,222 shares; 2025Q2: 398,309 shares; 2025Q3: 370,376 shares; 2025Q4: 825,576 shares; 2026Q1: 987,090 shares; 2026Q2: 1,620,753 shares; 2026Q3: 388,151 shares 388,151$4.77M0.72%-1,232,602Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 273,213 shares; 2025Q1: 234,834 shares; 2025Q2: 394,693 shares; 2025Q3: 431,693 shares; 2025Q4: 1,004,378 shares; 2026Q1: 537,628 shares; 2026Q2: 752,983 shares; 2026Q3: 349,383 shares 349,383$4.71M0.71%-403,600Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares; 2025Q4: 52,500 shares; 2026Q1: 55,110 shares; 2026Q2: 22,400 shares; 2026Q3: 22,400 shares 22,400$4.6M0.7%0Timeline
NVONOVO-NORDISK A SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 98,080 shares; 2025Q1: 118,080 shares; 2025Q2: 105,677 shares; 2025Q3: 105,677 shares; 2025Q4: 115,677 shares; 2026Q1: 120,677 shares; 2026Q2: 120,677 shares; 2026Q3: 120,677 shares 120,677$4.57M0.69%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 111,743 shares; 2025Q2: 128,515 shares; 2025Q3: 166,765 shares; 2025Q4: 226,765 shares; 2026Q1: 153,265 shares; 2026Q2: 112,765 shares; 2026Q3: 99,765 shares 99,765$4.57M0.69%-13,000Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 190,111 shares; 2026Q1: 136,015 shares; 2026Q2: 120,200 shares; 2026Q3: 2,315,696 shares 2,315,696$4.38M0.66%+2,195,496Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 115,908 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 187,438 shares 187,438$4.37M0.66%newTimeline
GSKGSK PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 130,000 shares; 2025Q1: 130,000 shares; 2025Q2: 122,000 shares; 2025Q3: 122,000 shares; 2025Q4: 122,000 shares; 2026Q1: 122,000 shares; 2026Q2: 102,000 shares; 2026Q3: 90,000 shares 90,000$4.34M0.66%-12,000Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 408,436 shares; 2026Q2: 233,836 shares; 2026Q3: 233,836 shares 233,836$4.22M0.64%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,211,533 shares; 2025Q1: 1,284,151 shares; 2025Q2: 1,310,233 shares; 2025Q3: 1,350,333 shares; 2025Q4: 1,178,164 shares; 2026Q1: 739,164 shares; 2026Q2: 756,164 shares; 2026Q3: 802,645 shares 802,645$4.14M0.63%+46,481Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 279,718 shares 279,718$4.08M0.62%newTimeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 288,539 shares; 2025Q1: not reported; 2025Q2: 174,900 shares; 2025Q3: 148,900 shares; 2025Q4: 212,202 shares; 2026Q1: 256,202 shares; 2026Q2: 356,534 shares; 2026Q3: 202,087 shares 202,087$4.07M0.62%-154,447Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,622,828 shares; 2026Q2: 1,353,000 shares; 2026Q3: 1,600,000 shares 1,600,000$3.98M0.6%+247,000Timeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 235,664 shares 235,664$3.77M0.57%newTimeline
MDWDMEDIWOUND LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 185,270 shares; 2025Q4: 230,347 shares; 2026Q1: 273,192 shares; 2026Q2: 273,192 shares; 2026Q3: 273,192 shares 273,192$3.76M0.57%0Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 176,663 shares; 2026Q3: 95,763 shares 95,763$3.76M0.57%-80,900Timeline
ACOGALPHA COGNITION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 620,000 shares; 2025Q1: 596,992 shares; 2025Q2: 376,649 shares; 2025Q3: 338,752 shares; 2025Q4: 567,616 shares; 2026Q1: 567,616 shares; 2026Q2: 545,816 shares; 2026Q3: 415,554 shares 415,554$3.74M0.57%-130,262Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 448,873 shares 448,873$3.71M0.56%newTimeline
IMMXIMMIX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 270,000 shares; 2026Q3: 355,800 shares 355,800$3.7M0.56%+85,800Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 232,294 shares; 2026Q3: 234,968 shares 234,968$3.6M0.55%+2,674Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 236,262 shares; 2025Q1: 329,262 shares; 2025Q2: 221,416 shares; 2025Q3: 426,518 shares; 2025Q4: 392,894 shares; 2026Q1: 160,594 shares; 2026Q2: 199,594 shares; 2026Q3: 222,564 shares 222,564$3.59M0.54%+22,970Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,551,619 shares; 2025Q1: 2,307,119 shares; 2025Q2: 1,959,610 shares; 2025Q3: 1,280,233 shares; 2025Q4: 2,132,131 shares; 2026Q1: 1,772,131 shares; 2026Q2: 1,191,187 shares; 2026Q3: 1,392,187 shares 1,392,187$3.52M0.53%+201,000Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 90,193 shares; 2025Q1: 78,193 shares; 2025Q2: 57,497 shares; 2025Q3: not reported; 2025Q4: 158,265 shares; 2026Q1: 94,265 shares; 2026Q2: 94,265 shares; 2026Q3: 72,265 shares 72,265$3.49M0.53%-22,000Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,491 shares; 2025Q1: 205,859 shares; 2025Q2: 183,094 shares; 2025Q3: 407,709 shares; 2025Q4: 407,709 shares; 2026Q1: 247,961 shares; 2026Q2: 244,961 shares; 2026Q3: 298,161 shares 298,161$3.43M0.52%+53,200Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 157,533 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$3.36M0.51%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 184,100 shares; 2026Q1: 1,733,471 shares; 2026Q2: 2,257,106 shares; 2026Q3: 2,464,038 shares 2,464,038$3.33M0.5%+206,932Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 455,604 shares; 2025Q1: 366,304 shares; 2025Q2: 196,635 shares; 2025Q3: 260,385 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 926,004 shares; 2026Q3: 1,035,004 shares 1,035,004$3.31M0.5%+109,000Timeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 122,752 shares; 2026Q1: 558,339 shares; 2026Q2: 1,019,832 shares; 2026Q3: 844,832 shares 844,832$3.3M0.5%-175,000Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 166,147 shares; 2026Q1: 78,234 shares; 2026Q2: 22,632 shares; 2026Q3: 390,632 shares 390,632$3.23M0.49%+368,000Timeline
LTGOLATIGO BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 192,120 shares 192,120$3.21M0.49%newTimeline
AAOIAPPLIED OPTOELECTRONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 73,400 shares; 2026Q2: not reported; 2026Q3: 32,210 shares 32,210$3.2M0.48%newTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 173,475 shares; 2026Q1: 173,475 shares; 2026Q2: 183,475 shares; 2026Q3: 221,379 shares 221,379$2.97M0.45%+37,904Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 474,103 shares; 2025Q1: 507,829 shares; 2025Q2: 419,540 shares; 2025Q3: 207,764 shares; 2025Q4: 239,764 shares; 2026Q1: 243,575 shares; 2026Q2: 240,868 shares; 2026Q3: 91,096 shares 91,096$2.95M0.45%-149,772Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,757,458 shares; 2026Q3: 1,757,458 shares 1,757,458$2.92M0.44%0Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 610,087 shares; 2025Q1: 343,522 shares; 2025Q2: 235,522 shares; 2025Q3: 245,522 shares; 2025Q4: 295,522 shares; 2026Q1: 295,522 shares; 2026Q2: 295,039 shares; 2026Q3: 267,539 shares 267,539$2.87M0.43%-27,500Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 408,166 shares; 2026Q1: 548,272 shares; 2026Q2: 638,272 shares; 2026Q3: 747,272 shares 747,272$2.76M0.42%+109,000Timeline
PMNPROMIS NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 11,807 shares; 2026Q1: 325,591 shares; 2026Q2: 325,591 shares; 2026Q3: 254,782 shares 254,782$2.76M0.42%-70,809Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 10,000 shares; 2025Q2: 9,500 shares; 2025Q3: 9,500 shares; 2025Q4: 7,500 shares; 2026Q1: 7,500 shares; 2026Q2: 7,500 shares; 2026Q3: 6,000 shares 6,000$2.53M0.38%-1,500Timeline
CABACABALETTA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,329,012 shares; 2026Q3: 1,263,612 shares 1,263,612$2.43M0.37%-65,400Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 460,985 shares; 2026Q3: 464,480 shares 464,480$1.9M0.29%+3,495Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 358,000 shares; 2026Q2: 219,700 shares; 2026Q3: 325,831 shares 325,831$1.72M0.26%+106,131Timeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 689,000 shares 689,000$1.61M0.24%newTimeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 109,200 shares 109,200$1.6M0.24%newTimeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 105,529 shares 105,529$1.48M0.22%newTimeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 649,309 shares; 2026Q3: 688,301 shares 688,301$1.41M0.21%+38,992Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 243,035 shares; 2026Q1: 86,518 shares; 2026Q2: 213,671 shares; 2026Q3: 182,562 shares 182,562$1.29M0.2%-31,109Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 420,000 shares; 2025Q3: 408,146 shares; 2025Q4: 368,146 shares; 2026Q1: not reported; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000$1.22M0.18%0Timeline
NTLAINTELLIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 466,080 shares; 2025Q1: 381,080 shares; 2025Q2: 128,780 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 90,250 shares 90,250$1.09M0.16%newTimeline
QNRXQUOIN PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 236,234 shares 236,234$1.08M0.16%newTimeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 18,821 shares 18,821$606K0.09%newTimeline
HOWLWEREWOLF THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 626,810 shares; 2025Q1: 626,810 shares; 2025Q2: 626,810 shares; 2025Q3: 626,810 shares; 2025Q4: 626,810 shares; 2026Q1: 626,810 shares; 2026Q2: 626,810 shares; 2026Q3: 626,810 shares 626,810$578K0.09%0Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 199,761 shares; 2025Q4: 339,761 shares; 2026Q1: 469,761 shares; 2026Q2: 427,554 shares; 2026Q3: 214,554 shares 214,554$575K0.09%-213,000Timeline
ORGOORGANOGENESIS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 550,000 shares; 2026Q2: 550,000 shares; 2026Q3: 330,000 shares 330,000$452K0.07%-220,000Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 220,000 shares; 2026Q2: 879,000 shares; 2026Q3: 125,395 shares 125,395$341K0.05%-753,605Timeline
TRAWTRAWS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 398,486 shares; 2026Q3: 398,486 shares 398,486$237K0.04%0Timeline
APREAPREA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 270,000 shares; 2025Q1: 270,000 shares; 2025Q2: 270,000 shares; 2025Q3: 270,000 shares; 2025Q4: 270,000 shares; 2026Q1: 270,000 shares; 2026Q2: 270,000 shares; 2026Q3: 270,000 shares 270,000$202K0.03%0Timeline
SKYESKYE BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,564,628 shares; 2025Q1: 1,476,353 shares; 2025Q2: 538,434 shares; 2025Q3: 478,928 shares; 2025Q4: 478,928 shares; 2026Q1: 678,928 shares; 2026Q2: 678,928 shares; 2026Q3: 87,264 shares 87,264$140K0.02%-591,664Timeline
CRISCURIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 39,665 shares 39,665$33.3K0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
XBISPDR SERIES TRUST S&P BIOTECHput75,000$11.8M-75,000
ARKGARK ETF TR GENOMIC REV ETFput200,000$10.8Mnew
HELPCYBIN INC COM NEWcall300,000$3.69Mnew
PRAXPRAXIS PRECISION MEDICINES I COM NEWcall12,500$3.64M0
TRVITREVI THERAPEUTICS INC Stockcall250,000$3.58Mnew
RAPPRAPPORT THERAPEUTICS INC Stockput100,000$3.36Mnew
CLDXCELLDEX THERAPEUTICS INC NEW COM NEWput100,000$3.24Mnew
TECXTECTONIC THERAPEUTIC INC COMMON STOCKcall100,000$2.33Mnew
SNDXSYNDAX PHARMACEUTICALS INC COMcall100,000$1.88Mnew
ANNXANNEXON INC COMput250,000$1.06Mnew
ANNXANNEXON INC COMcall250,000$1.06Mnew
IRONDISC MEDICINE INC Stockcall50,000$334Knew
TENXTENAX THERAPEUTICS INC COM NEWcall127,600$241K0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TEVATEVA PHARMACEUTICAL INDS LTD1,500,082$50.8Mshares
BIIBBIOGEN INC100,000$21.6Mcall
INSMINSMED INC118,800$12.7Mshares
CYTKCYTOKINETICS INC100,000$8.52Mcall
SOLAREDGE TECHNOLOGIES INCSOLAREDGE TECHNOLOGIES INC4,000,000$7.75Mshares
XENEXENON PHARMACEUTICALS INC105,000$6.34Mshares
ZBIOZENAS BIOPHARMA INC230,834$5.86Mshares
FBRXFORTE BIOSCIENCES INC249,693$5.31Mshares
VSTVISTRA CORP29,450$4.67Mshares
TLNTALEN ENERGY CORP12,135$4.66Mshares
CLOUGLOBAL X FDS195,900$4.45Mshares
BCRXBIOCRYST PHARMACEUTICALS INC422,051$4.22Mshares
GENBGENERATE BIOMEDICINES INC245,000$4.13Mshares
TLTISHARES TR47,000$4.06Mcall
KODKODIAK SCIENCES INC81,796$3.19Mshares
ORAORMAT TECHNOLOGIES INC28,015$3.05Mshares
ABVXABIVAX SA20,000$2.67Mput
BHVNBIOHAVEN LTD164,437$2.45Mshares
CEGCONSTELLATION ENERGY CORP9,850$2.45Mshares
VSTMVERASTEM INC632,632$2.42Mshares
GPCRSTRUCTURE THERAPEUTICS INC28,600$1.53Mshares
ORICORIC PHARMACEUTICALS INC100,000$1.08Mcall
CRISCURIS INC98,996$1.03Mshares
STTKSHATTUCK LABS INC86,461$600Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001496201-26-000006 base2026-11-16